<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>同写意 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-22T20:34:31+08:00</updated>
  <subtitle>一个以新药创制为核心，汇集国内一流研发精英的大型交流与价值分享平台。“同筑技术人生路，写意中国新药魂”是同写意的初衷与愿景。秉承汇集“一线、一流”，讲求“实用、实在、时效”的原则</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>礼来16亿美元启动和Merus的技术合作</title>
    <updated>2021-01-22T19:10:25+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-22:/s/MiNn3Qyn_jkPuEbieOzXYA</id>
    <link href="https://mp.weixin.qq.com/s/MiNn3Qyn_jkPuEbieOzXYA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>写意会员丨再鼎医药：鼎力创新，再泽生命</title>
    <updated>2021-01-22T19:10:25+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-22:/s/4ksFEyRFcnhwctNXuCHNMA</id>
    <link href="https://mp.weixin.qq.com/s/4ksFEyRFcnhwctNXuCHNMA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>关注杜丨2021年的首个FDA获批新药-VERQUVO</title>
    <updated>2021-01-22T19:10:25+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-22:/s/msGnHmtMTRIql2kjURxGDQ</id>
    <link href="https://mp.weixin.qq.com/s/msGnHmtMTRIql2kjURxGDQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>突破3000亿！百济神州新年收获加速</title>
    <updated>2021-01-22T19:10:25+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-22:/s/Tv-6lyv5veOjqNE5ppiY2w</id>
    <link href="https://mp.weixin.qq.com/s/Tv-6lyv5veOjqNE5ppiY2w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>癌症研究蓝图：挑战与机遇（下篇）</title>
    <updated>2021-01-21T19:24:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-21:/s/knOYpjLWoHwTA6oGcOKu9g</id>
    <link href="https://mp.weixin.qq.com/s/knOYpjLWoHwTA6oGcOKu9g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>50.4%与95%，差别不仅仅是疫苗，还有临床试验！</title>
    <updated>2021-01-21T19:24:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-21:/s/4OcF1RBYxPB4jPvfyBu9HQ</id>
    <link href="https://mp.weixin.qq.com/s/4OcF1RBYxPB4jPvfyBu9HQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>醋酸格拉替雷是不是生物产品？法院判决告诉你</title>
    <updated>2021-01-21T19:24:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-21:/s/k6doGbcixzGo5pqt5Ujttw</id>
    <link href="https://mp.weixin.qq.com/s/k6doGbcixzGo5pqt5Ujttw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>为什么美国不限制药物价格？</title>
    <updated>2021-01-21T19:24:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-21:/s/S5zXanqiyzN6H-m7FEsOuA</id>
    <link href="https://mp.weixin.qq.com/s/S5zXanqiyzN6H-m7FEsOuA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>License out！信达生物开启东南亚市场</title>
    <updated>2021-01-21T19:24:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-21:/s/a8jx2EC60N9buFlhS5riTw</id>
    <link href="https://mp.weixin.qq.com/s/a8jx2EC60N9buFlhS5riTw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>癌症研究蓝图：挑战与机遇（上篇）</title>
    <updated>2021-01-20T19:46:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-20:/s/Z9zZQy2Ysdj8vj4oERHfxA</id>
    <link href="https://mp.weixin.qq.com/s/Z9zZQy2Ysdj8vj4oERHfxA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>华烨博士：布局解决临床痛点药物，填补治疗空白！</title>
    <updated>2021-01-20T19:46:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-20:/s/XOKkjbZdjVdKbBWXJSRViA</id>
    <link href="https://mp.weixin.qq.com/s/XOKkjbZdjVdKbBWXJSRViA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>写意云课丨第65期：美国处方药市场与定价简析（下）</title>
    <updated>2021-01-20T19:46:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-20:/s/tVzkSDeu00fjYJE4BTIeFg</id>
    <link href="https://mp.weixin.qq.com/s/tVzkSDeu00fjYJE4BTIeFg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>同写意秘书处祝您大寒、腊八节快乐！</title>
    <updated>2021-01-20T19:46:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-20:/s/CTYTIvfPfSa5_iNzSvjUWw</id>
    <link href="https://mp.weixin.qq.com/s/CTYTIvfPfSa5_iNzSvjUWw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>临床试验影像终点指导原则落地！修订要点一览</title>
    <updated>2021-01-19T19:33:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/SF28orA0TWIIHgAcU8t5aw</id>
    <link href="https://mp.weixin.qq.com/s/SF28orA0TWIIHgAcU8t5aw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>逆流而上，2020中国生命科学领域投融资这一年</title>
    <updated>2021-01-19T19:33:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/1Tj0US2PYcEVqf6b0Pqyow</id>
    <link href="https://mp.weixin.qq.com/s/1Tj0US2PYcEVqf6b0Pqyow" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>小小疫苗瓶被“卡脖子”了吗？药用玻璃“内幕”了解一下！</title>
    <updated>2021-01-19T19:33:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/7X9XELewryafMrCLtWOUUg</id>
    <link href="https://mp.weixin.qq.com/s/7X9XELewryafMrCLtWOUUg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>PD-L1，打不起价格战</title>
    <updated>2021-01-19T19:33:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/xrWat0_BPeT2HfLDztPuZg</id>
    <link href="https://mp.weixin.qq.com/s/xrWat0_BPeT2HfLDztPuZg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>写意报告丨临床开发的重中之重—适应症的选择策略</title>
    <updated>2021-01-18T18:56:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/b_c-BtNd83H91mLDk6Jf_g</id>
    <link href="https://mp.weixin.qq.com/s/b_c-BtNd83H91mLDk6Jf_g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>写意发布丨丹诺医药与强生公司合作研发新药产品</title>
    <updated>2021-01-18T18:56:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/IjZlryt5kVjgy-YhRO6ZBQ</id>
    <link href="https://mp.weixin.qq.com/s/IjZlryt5kVjgy-YhRO6ZBQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>全面落实MAH制度，还有哪些挑战？</title>
    <updated>2021-01-18T18:56:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/4CsXEqUQK3qNeVgH_khAWg</id>
    <link href="https://mp.weixin.qq.com/s/4CsXEqUQK3qNeVgH_khAWg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>